0
PharmaMar Banner Image

PharmaMar has reached its limit for free report views

Work for PharmaMar? Upgrade Your Profile and unlock all your annual reports.

PharmaMar

  • Ticker
    Exchange
  • Industry Biotechnology More
  • Sector Healthcare More
PharmaMar Logo Image
  • 201-500 Employees
  • Based in Madrid, Spain
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissueMore sarcomas and for ovarian cancer; and Aplidin for treating multiple myeloma. The company also develops clinical-stage programs, including Lurbinectedin, PM184, and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
PharmaMar

Most Recent Annual Report

PharmaMar
MOST RECENT 2021 Annual Report

Report Locked. PharmaMar has reached its limit for free report views.

Older/Archived Annual Reports